KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesBeginning Cash BalanceCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther financing activitiesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Aquestive Therapeutics (AQST) Non-cash Items: 2018-2020

Historic Non-cash Items for Aquestive Therapeutics (AQST) over the last 3 years, with Dec 2020 value amounting to $1.2 million.

  • Aquestive Therapeutics' Non-cash Items rose 139.04% to $1.6 million in Q1 2021 from the same period last year, while for Mar 2021 it was $1.6 million, marking a year-over-year increase of 139.04%. This contributed to the annual value of $1.2 million for FY2020, which is 205.69% up from last year.
  • As of FY2020, Aquestive Therapeutics' Non-cash Items stood at $1.2 million, which was up 205.69% from $404,000 recorded in FY2019.
  • In the past 5 years, Aquestive Therapeutics' Non-cash Items ranged from a high of $1.2 million in FY2020 and a low of $87,000 during FY2018.
  • For the 3-year period, Aquestive Therapeutics' Non-cash Items averaged around $575,333, with its median value being $404,000 (2019).
  • Data for Aquestive Therapeutics' Non-cash Items shows a peak YoY skyrocketed of 364.37% (in 2019) over the last 5 years.
  • Aquestive Therapeutics' Non-cash Items (Yearly) stood at $87,000 in 2018, then soared by 364.37% to $404,000 in 2019, then spiked by 205.69% to $1.2 million in 2020.